Menu Menu

CCCC    C4 Therapeutics Inc    1662579    
Income Statement
Revenue 15,362,000
Net Income -24,666,000
Profit Margin -160.57%

Balance Sheet
Current Assets 273,228,000
Assets 376,060,000
Current Liabilities 43,293,000
Liabilities 133,404,000
Equity 242,656,000
Shares Out 69,338,000

Cash Flow Statement
Operating Cash Flow -47,225,000
Investing Cash Flow -64,940,000

Market Analysis
Market Cap 424,346,960
Price 3.94
BVPS 3.50
PB 1.13
EPS -1.90
PS 6.91
FCF -112,165,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/22
Apr May Jun
5/08 -0.41
Jul Aug Sep
8/01 -0.26
Oct Nov Dec
10/30

Find a discrepancy? The most accurate way to find company fundamental data is to view CCCC documents filed with the SEC.


CCCC Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: